Net Cash Provided by (Used in) Financing Activities |
147K |
USD |
-26.3% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
350M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
18.2M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
13 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
1.43M |
USD |
+268% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
1.43M |
USD |
+268% |
Mar 31, 2024 |
Q1 2024 |
Depreciation |
454K |
USD |
-100% |
Mar 31, 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Sep 30, 2023 |
Q3 2023 |
Property, Plant and Equipment, Gross |
534K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
5.87M |
USD |
+1.03% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.43M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Interest Expense |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |